Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tretinoin,Benzoyl Peroxide
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Sponsor : Apotex Inc
Deal Size : Undisclosed
Deal Type : Acquisition
Apotex Acquires Searchlight, a Canadian Specialty Innovative Branded Pharma Company
Details : Apotex will commercialize Twyneo (tretinoin), a retinoic acid receptor agonist in combination with Benzoyl Peroxide indicated for the topical treatment of acne vulgaris.
Product Name : Twyneo
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Undisclosed
March 06, 2024
Lead Product(s) : Tretinoin,Benzoyl Peroxide
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Sponsor : Apotex Inc
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Tretinoin,Benzoyl Peroxide
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Sponsor : Apotex Inc
Deal Size : Undisclosed
Deal Type : Acquisition
Apotex to Acquire Searchlight Pharma, a Canadian Specialty Branded Pharmaceutical Leader
Details : Through acquisition, Apotex will commercialize Twyneo (tretinoin), a retinoic acid receptor agonist combined with Benzoyl Peroxide for treating acne vulgaris in patients aged 9 and older.
Product Name : Twyneo
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Undisclosed
February 04, 2024
Lead Product(s) : Tretinoin,Benzoyl Peroxide
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Sponsor : Apotex Inc
Deal Size : Undisclosed
Deal Type : Acquisition